Current strategies for myocardial gene delivery
Authors:
- JaBaris D. SwainJSJaBaris D. Swain
- Catherine E. TomasuloCTCatherine E. Tomasulo
- Marina SumarokaMSMarina Sumaroka
- Anthony FargnoliAFAnthony Fargnoli
- Charles R. BridgesCBCharles R. Bridges
- 1 May 2011
- journal article
- review article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 50 (5) , 766-776
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical TrialJournal of Cardiac Failure, 2009
- Myocardial Adeno-Associated Virus Serotype 6–βARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart FailureCirculation, 2009
- Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animalsGene Therapy, 2008
- Gene Therapy in Heart FailureCirculation Research, 2008
- Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockadeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virusThe Journal of Gene Medicine, 2004
- Widespread regional myocardial transfection by plasmid encoding Del-1 following retrograde coronary venous deliveryCatheterization and Cardiovascular Interventions, 2003
- Adenovirus–Catheter Compatibility Increases Gene Expression After Delivery to Porcine MyocardiumHuman Gene Therapy, 2003
- Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene deliveryJournal of Clinical Investigation, 1999
- Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectorsClinical Cardiology, 1999